Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.59 -0.05 (-3.05%)
As of: Oct 1, 2026 · 9:30 AM EDT

Processa Pharmaceuticals (PCSA) Non Operating Income (2025 - 2026)

Updated

Processa Pharmaceuticals (PCSA) recorded Non Operating Income of -$929,356 in Q2 2026, compared with $16,865 a year earlier.

Analysis

Processa Pharmaceuticals (PCSA) Non Operating Income (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Processa Pharmaceuticals 4.58 Mn 4.58 Mn - -929,356.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -929,356.00
Jun 30, 2025 16,865.00
API Access

Processa Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=PCSA&period=max&api_key=YOUR_API_KEY